APLM Gets Nasdaq Delisting Warning for Sub-$1.00 Bid Price
Ticker: APLMW · Form: 6-K · Filed: Jan 19, 2024 · CIK: 1944885
| Field | Detail |
|---|---|
| Company | Apollomics Inc. (APLMW) |
| Form Type | 6-K |
| Filed Date | Jan 19, 2024 |
| Risk Level | medium |
| Pages | 1 |
| Reading Time | 1 min |
| Key Dollar Amounts | $1.00 |
| Sentiment | bearish |
Complexity: simple
Sentiment: bearish
Topics: delisting-risk, nasdaq-compliance, biopharmaceutical, regulatory-filing
TL;DR
**APLM got a Nasdaq warning for its low stock price; they have until July 15 to fix it or risk delisting.**
AI Summary
Apollomics Inc. (APLM) received a notice from Nasdaq on January 16, 2024, indicating non-compliance with the minimum $1.00 bid price requirement. The company now has an initial 180-day period, until July 15, 2024, to regain compliance. This matters to investors because failure to meet this requirement could lead to delisting from Nasdaq, potentially reducing the stock's liquidity and investor interest.
Why It Matters
This notice signals potential delisting risk for Apollomics, which could negatively impact the stock's liquidity and make it less attractive to institutional investors.
Risk Assessment
Risk Level: medium — The company faces a clear risk of delisting if its share price does not recover above $1.00 by July 15, 2024.
Analyst Insight
A smart investor would monitor APLM's stock price performance closely and research any potential corporate actions (like a reverse stock split) that the company might take to regain Nasdaq compliance before July 15, 2024. Consider the implications of potential delisting on liquidity and future investment.
Key Numbers
- $1.00 — Minimum Bid Price (Nasdaq's required minimum closing bid price per share)
- 180 days — Compliance Period (initial period granted to Apollomics to regain compliance)
Key Players & Entities
- Apollomics Inc. (company) — the registrant receiving the Nasdaq notice
- Nasdaq Stock Market LLC (company) — the exchange issuing the non-compliance notice
- Guo-Liang Yu (person) — Chief Executive Officer of Apollomics Inc.
- $1.00 (dollar_amount) — the minimum closing bid price requirement
- January 16, 2024 (date) — date Apollomics received the Nasdaq notification
- July 15, 2024 (date) — deadline for Apollomics to regain compliance
Forward-Looking Statements
- Apollomics will implement strategies to increase its stock price above $1.00. (Apollomics Inc.) — medium confidence, target: July 15, 2024
- If the stock price does not recover, Apollomics may consider a reverse stock split. (Apollomics Inc.) — medium confidence, target: July 15, 2024
FAQ
What specific Nasdaq Listing Rule did Apollomics Inc. violate?
Apollomics Inc. violated Nasdaq Listing Rule 5550(a)(2), which requires a minimum closing bid price of $1.00 per share.
When did Apollomics Inc. receive the non-compliance notification from Nasdaq?
Apollomics Inc. received the notification from Nasdaq on January 16, 2024.
What is the deadline for Apollomics Inc. to regain compliance with Nasdaq's minimum bid price requirement?
Apollomics Inc. has an initial 180-day period through July 15, 2024, to regain compliance.
Who signed the 6-K report on behalf of Apollomics Inc.?
The 6-K report was signed by Guo-Liang Yu, Chief Executive Officer of Apollomics Inc., on January 19, 2024.
What is the primary business of Apollomics Inc.?
Apollomics Inc. is a clinical-stage biopharmaceutical company developing medicines to address difficult-to-treat cancers.
Filing Stats: 201 words · 1 min read · ~1 pages · Grade level 9.4 · Accepted 2024-01-19 16:34:56
Key Financial Figures
- $1.00 — maintain a minimum closing bid price of $1.00 per share. A copy of the press release
Filing Documents
- d737872d6k.htm (6-K) — 9KB
- d737872dex991.htm (EX-99.1) — 10KB
- g737872g0119103015715.jpg (GRAPHIC) — 2KB
- 0001193125-24-011285.txt ( ) — 23KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. APOLLOMICS INC Date: January 19, 2024 By: /s/ Guo-Liang Yu Name: Guo-Liang Yu Title: Chief Executive Officer